TSE:4506Pharmaceuticals
Stronger Q1 Earnings Might Change The Case For Investing In Sumitomo Pharma (TSE:4506)
Sumitomo Pharma Co., Ltd. reported first-quarter 2026 results, with sales rising to ¥129,495 million and net income to ¥16,997 million, lifting basic earnings per share from continuing operations to ¥39.02, all compared with the same period a year earlier.
The strong year-on-year improvement in profitability, especially the higher earnings per share, highlights how recent operational performance may be influencing investor expectations for the business.
We’ll now examine how this jump in...